Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study

Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction

(2014) Matthew W Johnson et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction

(2013) Kathryn A. Cunningham et al.   NEUROPHARMACOLOGY

A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment

(2013) Brittany Vasae Burdick et al.   AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE

Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors

(2012) Michael Kometer et al.   BIOLOGICAL PSYCHIATRY

Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses

(2012) Michael P. Bogenschutz et al.   Drug Testing and Analysis

Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials

(2012) Teri S Krebs et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

(2012) R. L. Carhart-Harris et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Functional Connectivity Measures After Psilocybin Inform a Novel Hypothesis of Early Psychosis

(2012) Robin L. Carhart-Harris et al.   SCHIZOPHRENIA BULLETIN

Serotonin receptor, SERT mRNA and correlations with symptoms in males with alcohol dependence and suicide

(2011) P. M. Thompson et al.   ACTA PSYCHIATRICA SCANDINAVICA

Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers

(2011) Matthew W. Johnson et al.   DRUG AND ALCOHOL DEPENDENCE

Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness

(2011) Katherine A MacLean et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

(2011) Roland R. Griffiths et al.   PSYCHOPHARMACOLOGY

Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer

(2010) Charles S. Grob et al.   ARCHIVES OF GENERAL PSYCHIATRY

Increased Serotonin 2A Receptor Availability in the Orbitofrontal Cortex of Physically Aggressive Personality Disordered Patients

(2010) Daniel R. Rosell et al.   BIOLOGICAL PSYCHIATRY

The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

(2010) Franz X. Vollenweider et al.   NATURE REVIEWS NEUROSCIENCE

Psychedelics and the Human Receptorome

(2010) Thomas S. Ray   PLoS One

Decreased cerebral cortex and liver 5-HT2Areceptor gene expression and enhanced ALDH activity in ethanol-treated rats and hepatocyte cultures

(2009) Akash K. George et al.   NEUROLOGICAL RESEARCH

Role of BDNF and GDNF in drug reward and relapse: A review

(2009) Udi E. Ghitza et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Rapid modulation of spine morphology by the 5-HT2A serotonin receptor through kalirin-7 signaling

(2009) K. A. Jones et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Family History of Alcoholism Is Associated With Lower 5-HT2AReceptor Binding in the Prefrontal Cortex

(2008) Mark D. Underwood et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Enhanced 5-HT2A Receptor Status in the Hypothalamus and Corpus Striatum of Ethanol-Treated Rats

(2008) K. G. Akash et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

Enhanced dopamine D2 receptor function in hypothalamus and corpus striatum: their role in liver, plasma and in vitro hepatocyte ALDH regulation in ethahol treated rats

(2008) K. G. Akash et al.   JOURNAL OF BIOMEDICAL SCIENCE

Serotonin (5-HT) induces glial cell line-derived neurotrophic factor (GDNF) mRNA expression via the transactivation of fibroblast growth factor receptor 2 (FGFR2) in rat C6 glioma cells

(2008) Mami Tsuchioka et al.   JOURNAL OF NEUROCHEMISTRY

Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later

(2008) RR Griffiths et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Elevated 5-HT 2A receptors in postmortem prefrontal cortex in major depression is associated with reduced activity of protein kinase A

(2008) R.C. Shelton et al.   NEUROSCIENCE

Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings

(2007) Bankole A. Johnson   BIOCHEMICAL PHARMACOLOGY

Frontolimbic Serotonin 2A Receptor Binding in Healthy Subjects Is Associated with Personality Risk Factors for Affective Disorder

(2007) Vibe G. Frokjaer et al.   BIOLOGICAL PSYCHIATRY